Search results for PX-TA1342

Showing 1 – 10 of1products
Bimekizumab Biosimilar – Anti-IL17A, IL17F mAb – Research Grade Brand Logo
ID: BAB053731192

Bimekizumab Biosimilar – Anti-IL17A, IL17F mAb – Research Grade, ProteoGenix, PX-TA1342

Description of Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade General information on Anti-IL17A[Homo sapiens] (Bimekizumab) Monoclonal Antibody Bimekizumab has beeninvestigated for the treatment of Psoriatic arthritis, Ankylosing Spondylitis, Chronic Plaque Psoriasis, and Mild to Moderate Psoriasis.

Host

Reactivity

Applications

Conjugation

Request a product

Please provide the required information below so that we can quickly source your products.